Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA.
about
Eat dirt: CpG DNA and immunomodulation of asthmaNew strategies for allergen T cell epitope identification: going beyond IgEImmunological mechanisms of allergen-specific immunotherapyMonoclonal antibodies and other biologic agents in the treatment of asthmaRole of infections in the induction and development of asthma: genetic and inflammatory driversTargeting allergen to Fc gammaRI: a strategy to treat allergic disease?Ragweed-induced allergic rhinoconjunctivitis: current and emerging treatment options.Toll-like receptor-9 agonist inhibits airway inflammation, remodeling and hyperreactivity in mice exposed to chronic environmental tobacco smoke and allergenThe dichotomy of pathogens and allergens in vaccination approachesTargeting Toll-like receptors on dendritic cells modifies the T(H)2 response to peanut allergens in vitro.Targeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses.Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergyTranslational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders.In vitro effects of CpG oligodeoxynucleotides delivered by gelatin nanoparticles on canine peripheral blood mononuclear cells of atopic and healthy dogs - a pilot study.Role of Toll-like receptors in antisense and siRNA [corrected].A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice.Immunostimulatory oligonucleotides in therapy of allergic diseases.Advances in allergen-specific immunotherapy.Targets in allergy-directed immunotherapy.Emerging anti-inflammatory agents for allergic rhinitis.T regulatory cells and the control of allergic disease.Modern approaches to therapeutic vaccination as treatment for type 1 respiratory hypersensitivity (allergy) treatment.Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.The regulation of allergy and asthma.Sublingual immunotherapy of allergic diseases.Regulation of the T cell response.Novel therapeutic interventions for allergic rhinitis.Immune responses to inhalant allergens.Allergen immunotherapy for allergic respiratory diseasesCPG-7909 (PF-3512676, ProMune): toll-like receptor-9 agonist in cancer therapy.Immunostimulatory DNA as a vaccine adjuvant.The role of innate immunity in the pathogenesis of asthma: evidence for the involvement of Toll-like receptor signaling.Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function.CpG-containing immunostimulatory DNA sequences elicit TNF-alpha-dependent toxicity in rodents but not in humans.Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.Immunomodulation of allergic diseaseInvestigational drugs for allergic rhinitis.Combination adjuvants: the next generation of adjuvants?Assessing the safety of adjuvanted vaccines.Prophylactic and therapeutic implications of toll-like receptor ligands.
P2860
Q24648479-041E7238-9314-4747-97E9-1C54404E4029Q26824787-07BAAA72-7EE6-41CC-8870-9496AE4065D6Q28265326-2E945D62-7675-4EBB-B965-40D996F32227Q28270037-6A580006-6B16-4A03-A807-B77D4BF221D8Q28389983-6E861636-9A58-466A-AC0D-61733DEB9B76Q30437725-BF2D5CB9-EB6D-4326-800F-2C275369EC3FQ30903098-F80A5CBA-E4D5-4565-BE34-0EB016CC0205Q33785118-32B69352-45EE-4FA1-9977-B84CB2A82248Q33909251-F19BF570-B0C2-4EC2-94FC-37D4B4D453F4Q33987620-F52014AC-804E-49EA-9B26-84588250DEB5Q34048648-3CF1D88E-BD51-42DF-97E3-AB4D248CE0BBQ34099820-67035657-D3FF-4777-A1BF-31803D1A05F3Q34602052-54BF3EB4-78E0-43C4-A448-0B344F43622FQ34798245-02E28583-B95B-4861-8F35-E04D297774A7Q35975656-F0FC3C89-37C1-4AA0-A59D-C6DAFDD8709BQ36023560-4BFF7F37-8AE9-4869-95F9-1FFDC946245EQ36150438-E9AFCBBC-6AD5-422D-88BE-D0B07E59B396Q36150445-DD189114-4B94-4130-9A99-8612F46C2E2CQ36150810-87E9ABFB-CD63-4758-BB64-7B775390BAF0Q36302823-4F857921-007C-4951-8A1F-7B2BD07989F5Q36377204-7821721F-1B37-4CD0-BAF0-A595E1BC25E8Q36383791-CA90D4E2-11CF-461F-B2D9-496E3079AF27Q36526351-8306F2CD-1764-43A5-88B1-96624ECE8527Q36563540-A9FF057E-CFB0-40D7-81A8-9ED85187C09EQ36583727-2DA6109C-FB7D-4684-BB10-265A6397F86AQ36643790-3963003F-4B07-4BB2-906A-7F6A9686A188Q36654345-BC93E7C1-381A-49CC-A289-0ECC7DCD4557Q36834308-1AA2351F-E7B2-4F3D-A9AC-B9D1D70D1987Q36864947-9493197E-D122-49DE-BFF9-EA6E2DDCF580Q36909391-71E7B8E7-0C55-4335-8384-A0798E3FD55EQ36968274-E84040EE-E191-4B24-81FA-2EED4D332F57Q36994697-A84ED423-1DA5-473E-86B7-FFCF69F75F60Q37073695-E8857153-845A-4F72-9CAD-082B68F11FE7Q37328524-D6AF6A0B-AA37-4B10-AB9A-F11E8685649CQ37497786-6FDE007A-FAFD-4737-858B-5828162A5004Q37561129-E2C493AA-3C92-4D3B-9C45-A54AF92D21E7Q37650382-013C2844-59AE-4A49-8E1B-3AD09AEB0BB1Q37821483-B1F9F01E-0AD0-4F92-BE6A-CE98416BD013Q37906961-E0CE7531-D127-4CB3-BD53-FCE078896B23Q37989884-D0520D05-B2DA-4301-8669-1E89AA60DCAD
P2860
Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Selective immune redirection i ...... nked to immunostimulatory DNA.
@en
Selective immune redirection i ...... nked to immunostimulatory DNA.
@nl
type
label
Selective immune redirection i ...... nked to immunostimulatory DNA.
@en
Selective immune redirection i ...... nked to immunostimulatory DNA.
@nl
prefLabel
Selective immune redirection i ...... nked to immunostimulatory DNA.
@en
Selective immune redirection i ...... nked to immunostimulatory DNA.
@nl
P2093
P1476
Selective immune redirection i ...... nked to immunostimulatory DNA.
@en
P2093
F Estelle R Simons
Gary Van Nest
Joseph J Eiden
Kent T HayGlass
Yasufumi Shikishima
P304
P356
10.1016/J.JACI.2004.03.003
P407
P577
2004-06-01T00:00:00Z